Learn more

SOLIPHARMA LLC

Overview
  • Total Patents
    57
  • GoodIP Patent Rank
    31,238
  • Filing trend
    ⇩ 80.0%
About

SOLIPHARMA LLC has a total of 57 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2013. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and materials and metallurgy are ACTUATE THERAPEUTICS INC, SICHUAN CREDIT PHARMA CO LTD and VERTEX PHARMACEUTICALS EUROPE LTD.

Patent filings in countries

World map showing SOLIPHARMA LLCs patent filings in countries

Patent filings per year

Chart showing SOLIPHARMA LLCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Sheng Xiaoxia 57
#2 Sheng Xiaohong 41
#3 Tang Yong 8
#4 Zheng Jianfeng 8
#5 Xu Yinrong 7
#6 Wang Jing 7
#7 Hu Chenyang 5
#8 Zhu Tao 4
#9 Shen Tao 4
#10 Li Yongxin 3

Latest patents

Publication Filing date Title
WO2019062854A1 Co-crystals of ribociclib and co-crystals of ribociclib mono-succinate, preparation method therefor, compositions thereof, and uses thereof
CN110317159A A kind of novel crystal forms and preparation method thereof of Lu AE58054
CN108239055A A kind of THR1442 L-Aspartic acids eutectic, preparation method and pharmaceutical composition
CN110944979A ODM-201 crystal form, preparation method and pharmaceutical composition thereof
CN110944978A Compound containing entinostat, compound crystal form thereof, preparation method and pharmaceutical composition
CN110612292A Crystal form of addition salt of ozapimod, preparation method, pharmaceutical composition and application
CN110582279A Co-crystals of 2- (6-methyl-pyridin-2-yl) -3-yl- [ 6-amido-quinolin-4-yl ] -5, 6-dihydro-4H-pyrrolo [1,2-b ] pyrazole, processes for their preparation and pharmaceutical compositions containing them
CN110582497A Crystalline forms of 2- (6-methyl-pyridin-2-yl) -3-yl- [ 6-amido-quinolin-4-yl ] -5, 6-dihydro-4H-pyrrolo [1,2-b ] pyrazole, methods of preparation, and pharmaceutical compositions thereof
WO2018148961A1 Crystal form of acp-196 salt and preparation method, pharmaceutical composition, and use thereof
WO2018103027A1 Crystal form of tipifarnib and preparation method and pharmaceutical composition thereof
CN108137536A A kind of crystal form of receptor stimulating agent and preparation method thereof and pharmaceutical composition
WO2018064797A1 Crystal form of acp-196, preparation method therefor and pharmaceutical composition thereof
WO2018058296A1 Ttp488 addition salts, crystal forms thereof, preparation methods therefor, and pharmaceutical compositions thereof
WO2018049632A1 Crystal form of ozanimod, and preparation method and pharmaceutical composition thereof
CN108299391A Crystal form of linatinib 2-maleate and preparation method thereof and pharmaceutical composition
US2017072058A1 Pharmaceutical composition containing tacrolimus and preparation methods thereof
WO2016070696A1 Dosing preparation of dabigatran etexilate or a salt thereof and a preparation method thereof
CN106146446A The clean semihydrate of Da Gelie and crystal formation, its preparation method and pharmaceutical composition
CN106999434A A kind of micropill containing cysteine hydrochloride and preparation method thereof
CN104610185A Recovery method of valsartan mother liquor